HAE (STOCKS)
Haemonetics Corporation
$73.700000
-3.210000 (-4.17%)
Prev close: $76.910000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Christopher A. Simon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,349.37M
- Employees
- 3,023
- P/E (TTM)
- 37.43
- P/B (TTM)
- 4.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q4)
|
$1.29 | $1.28 | +0.0054 | +0.42% |
|
Dec 2025 (Q3)
|
$1.31 | $1.26 | +0.0473 | +3.75% |
|
Sep 2025 (Q2)
|
$1.27 | $1.12 | +0.1487 | +13.26% |
|
Jun 2025 (Q1)
|
$1.10 | $1.03 | +0.0738 | +7.19% |
Financial Statements
| Revenues | $1.33B |
| Benefits Costs and Expenses | $1.21B |
| Cost Of Revenue | $546.44M |
| Costs And Expenses | $1.21B |
| Gross Profit | $787.59M |
| Operating Expenses | $630.85M |
| Selling, General, and Administrative Expenses | $442.42M |
| Depreciation and Amortization | $111.72M |
| Research and Development | $59.77M |
| Other Operating Expenses | $16.95M |
| Operating Income/Loss | $156.73M |
| Income/Loss From Continuing Operations After Tax | $97.31M |
| Income/Loss From Continuing Operations Before Tax | $128.03M |
| Income Tax Expense/Benefit | $30.72M |
| Income Tax Expense/Benefit, Current | $57.12M |
| Income Tax Expense/Benefit, Deferred | -$26.40M |
| Net Income/Loss | $97.31M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $97.31M |
| Net Income/Loss Available To Common Stockholders, Basic | $97.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.06 |
| Diluted Earnings Per Share | $2.05 |
| Basic Average Shares | 47,179,000 |
| Diluted Average Shares | 47,354,000 |
| Assets | $2.40B |
| Current Assets | $834.88M |
| Inventory | $306.37M |
| Other Current Assets | $528.51M |
| Noncurrent Assets | $1.56B |
| Fixed Assets | $305.76M |
| Intangible Assets | $447.66M |
| Other Non-current Assets | $807.63M |
| Liabilities | $1.60B |
| Current Liabilities | $282.60M |
| Accounts Payable | $51.06M |
| Wages | $68.19M |
| Other Current Liabilities | $163.35M |
| Noncurrent Liabilities | $1.32B |
| Long-term Debt | $1.24B |
| Other Non-current Liabilities | $77.20M |
| Equity | $796.32M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $796.32M |
| Liabilities And Equity | $2.40B |
| Net Cash Flow From Operating Activities | $293.22M |
| Net Cash Flow From Operating Activities, Continuing | $293.22M |
| Net Cash Flow From Investing Activities | -$179.55M |
| Net Cash Flow From Investing Activities, Continuing | -$179.55M |
| Net Cash Flow From Financing Activities | -$178.46M |
| Net Cash Flow From Financing Activities, Continuing | -$178.46M |
| Exchange Gains/Losses | $3.46M |
| Net Cash Flow | -$61.32M |
| Net Cash Flow, Continuing | -$64.79M |
| Comprehensive Income/Loss | $114.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $114.78M |
| Other Comprehensive Income/Loss | $17.47M |